Skip to main content
Premium Trial:

Request an Annual Quote

Viva la Revolución de … 23andMe

With its new Research Revolution, 23andMe says it will "jumpstart genetic research" into certain diseases by engaging the community. According to the Spittoon, this project will help "large groups of people to assemble themselves into large-scale genetic studies." People vote for the disease they are interested in and once 1,000 people are signed up, the study commences — participants receive the scaled-down Research Edition of the 23andMe service for $99. The 10 diseases under study are: ALS, celiac disease, epilepsy, lymphoma and leukemia, migraines, multiple sclerosis, psoriasis, rheumatoid arthritis, severe food allergies, and testicular cancer. Genetic Future's Daniel MacArthur weighs in. "Let me be perfectly frank - it's unlikely that a genome-wide association study with only 1,000 patients will reveal any novel genetic associations, especially for those diseases on the list," he writes. He later adds that "23andMe's goals are clearly far beyond this: they aim to build stable, self-sustaining communities of potential research participants, that add new members over time and are available to add further trait data."

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.